Ongoing lawsuits allege GLP-1s can cause serious harm. But we don't know how often

Legal battles and growing concerns are swirling around GLP-1 drugs, commonly prescribed for weight loss and diabetes, due to allegations of serious side effects including blindness and pancreatitis. Despite these lawsuits, precise data on the frequency of these adverse effects remains sparse, complicating both scientific evaluations and legal proceedings. The lack of comprehensive information raises significant questions about the safety and regulation of these medications, underscoring the urgent need for more thorough research and transparency from pharmaceutical companies.